ArticlePediatric pulmonology2022

Elexacaftor-Tezacaftor-Ivacaftor improves exercise capacity in adolescents with cystic fibrosis.

Adam J Causer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.